We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Dezima In-Licenses CETP Inhibitor Program from MTPC

News   Apr 25, 2013

 
Dezima In-Licenses CETP Inhibitor Program from MTPC
 
 
Advertisement
 

RELATED ARTICLES

"Floppy" Proteins Used To Create Artificial Organelles Within Human Cells

News

Biomedical engineers have developed a method for controlling the phase separation of an emerging class of proteins to create artificial membrane-less organelles within human cells.

READ MORE

How a Protein Protects Cells From Death

News

New research has illustrated how a protein inside the body reduces the adverse effects of hypertonicity, including cell death.

READ MORE

RLF-100 Trial Shows Rapid Recovery From Respiratory Failure in Critically Ill Patients With COVID-19

News

A clinical trial of RLF-100 (aviptadil) has shown rapid recovery from respiratory failure in critically ill patients with COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE